Fractional Chloride Excretion in Acute Kidney Injury
Fractional chloride excretion (FECl) is calculated as (urine chloride × serum creatinine) / (serum chloride × urine creatinine) × 100%, and values <1% suggest prerenal azotemia while values >1% indicate intrinsic kidney injury, though this metric has largely been superseded by fractional excretion of sodium (FENa) in clinical practice.
Calculation Formula
The fractional excretion of chloride is calculated using the following formula:
FECl (%) = (Urine Chloride × Serum Creatinine) / (Serum Chloride × Urine Creatinine) × 100
This parallels the calculation for FENa, substituting chloride values for sodium values.
Clinical Interpretation
Threshold Values
- FECl <1%: Suggests prerenal azotemia (volume depletion, hepatorenal syndrome)
- FECl >1%: Suggests intrinsic renal injury (acute tubular necrosis)
Advantages Over FENa
Urinary chloride concentration demonstrates superior diagnostic accuracy compared to urinary sodium in specific clinical scenarios 1. In a prospective study of 99 patients with acute renal failure:
- Urinary chloride <20 mEq/L identified prerenal azotemia in 20 of 21 cases (95% sensitivity)
- Urinary sodium <20 mEq/L identified only 13 of 21 cases (62% sensitivity)
- FECl showed greater sensitivity with equivalent specificity compared to FENa 1
The key advantage emerges in metabolic alkalosis with bicarbonaturia, where urinary sodium becomes falsely elevated (65 ± 19 mEq/L) while urinary chloride remains appropriately low (4.0 ± 1.0 mEq/L) in prerenal states 1.
Clinical Context and Limitations
When FECl/FENa Are Most Useful
According to recent meta-analysis, fractional excretion indices perform optimally in oliguric patients without CKD or diuretic exposure, achieving 95% sensitivity and 91% specificity 2. The diagnostic accuracy deteriorates significantly in:
- Patients on diuretics: Sensitivity 80%, specificity only 54% 2
- Patients with CKD: Sensitivity 83%, specificity 66% 2
Current Guideline Perspective on Fractional Excretion Indices
Modern guidelines have moved away from relying heavily on fractional excretion indices for AKI differentiation 3. In cirrhotic patients specifically:
- FENa <1% had 100% sensitivity but only 14% specificity for prerenal causes 3
- Fractional excretion of urea (FEUrea) <28.16% demonstrated superior performance with 75% sensitivity and 83% specificity for differentiating hepatorenal syndrome from other causes 3
The International Club of Ascites guidelines 4 emphasize that response to volume expansion with albumin (1 g/kg for 2 days) is more clinically relevant than fractional excretion calculations for distinguishing prerenal from intrinsic AKI in cirrhosis.
Practical Clinical Algorithm
Step 1: Assess Clinical Context
- Oliguric + no diuretics + no CKD: FECl/FENa highly reliable
- Diuretics or CKD present: FECl/FENa unreliable; proceed to Step 2
- Cirrhosis with ascites: Consider FEUrea instead; proceed to therapeutic trial
Step 2: Therapeutic Approach Over Calculation
Rather than relying on fractional excretion indices, withdraw nephrotoxic agents and diuretics, then administer volume expansion 4:
- Full response: Serum creatinine returns to within 0.3 mg/dL of baseline → prerenal etiology
- No response: Persistent elevation → intrinsic AKI
Step 3: Additional Diagnostic Tools
If differentiation remains unclear:
- Urine microscopy (bland sediment = prerenal/HRS; muddy brown casts = ATN)
- Urine biomarkers (NGAL, KIM-1 for tubular injury) 3
- Renal ultrasound to exclude obstruction
Critical Pitfalls to Avoid
Do not use FECl/FENa in patients recently given diuretics - values become unreliable with fractional excretion >1% despite prerenal physiology 3, 1
Do not rely on FECl/FENa in metabolic alkalosis - use urinary chloride concentration directly (<20 mEq/L suggests prerenal) rather than fractional excretion 1
Do not use estimated GFR formulas during AKI - MDRD and CKD-EPI require steady-state creatinine and are inaccurate in cirrhosis 3, 5
Do not delay treatment to obtain fractional excretion values - empiric volume expansion and nephrotoxin withdrawal should begin immediately in Stage 1 AKI 4
Bottom Line for Clinical Practice
While fractional chloride excretion can theoretically differentiate prerenal from intrinsic AKI, its clinical utility is limited to a narrow patient population (oliguric, no diuretics, no CKD). In real-world practice, response to volume resuscitation provides more reliable diagnostic and prognostic information than any fractional excretion calculation 3, 4. The 2022 AGA guidelines and 2015 International Club of Ascites consensus explicitly prioritize therapeutic trials over biochemical indices for AKI differentiation 3, 4.